Literature DB >> 3029538

Human myeloperoxidase and hemi-myeloperoxidase.

P C Andrews, N I Krinsky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3029538     DOI： 10.1016/s0076-6879(86)32022-6

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN： 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  6 in total

1.  Molecular evidence that melatonin is enzymatically oxidized in a different manner than tryptophan: investigations with both indoleamine 2,3-dioxygenase and myeloperoxidase.

Authors:  Gilles Ferry; Caroline Ubeaud; Pierre-Hervé Lambert; Sophie Bertin; Francis Cogé; Pascale Chomarat; Philippe Delagrange; Bernard Serkiz; Jean-Paul Bouchet; Roger J W Truscott; Jean A Boutin
Journal:  Biochem J       Date:  2005-05-15       Impact factor: 3.857

2.  Neutrophil and recombinant myeloperoxidase as antigens in ANCA positive systemic vasculitis.

Authors:  A K Short; C M Lockwood; A Bollen; N Moguilevsky
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

3.  Studies of epitope restriction on myeloperoxidase (MPO), an important antigen in systemic vasculitis.

Authors:  A K Short; C M Lockwood
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

4.  Oxygen radical production and trapping in subjects with previous Yersinia infection.

Authors:  M Ristola; T Metsä-Ketelä; M Leirisalo-Repo; H Repo
Journal:  Inflammation       Date:  1992-06       Impact factor: 4.092

5.  Molecular characteristics of anti-self antibody fragments against neutrophil cytoplasmic antigens from human V gene phage display libraries.

Authors:  R Finnern; J M Bye; K M Dolman; M H Zhao; A Short; J D Marks; M C Lockwood; W H Ouwehand
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

6.  Age-dependent pulmonary clearance of Pseudomonas aeruginosa in a mouse model: diminished migration of polymorphonuclear leukocytes to N-formyl-methionyl-leucyl-phenylalanine.

Authors:  D O Sordelli; M Djafari; V E García; P A Fontán; G Döring
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.